See the DrugPatentWatch profile for lipitor

Yes, muscle fatigue during workouts can be a side effect of Lipitor (atorvastatin), a medication used to treat high cholesterol levels. Lipitor works by reducing the amount of cholesterol produced by the body, which can help prevent heart disease and stroke. However, like all medications, it can have side effects.

Muscle-related side effects are relatively common with Lipitor and other statins, a class of cholesterol-lowering drugs. These muscle-related side effects can range from mild to severe and may include muscle pain, weakness, cramps, and fatigue. It is important to note that while muscle fatigue during workouts can be a side effect of Lipitor, it can also be a symptom of other conditions, so it is essential to consult with a healthcare provider to determine the cause.

According to DrugPatentWatch.com, Lipitor was first approved by the FDA in 1996 and is manufactured by Pfizer. The website also notes that Lipitor is one of the best-selling drugs of all time, with billions of dollars in annual sales.

In summary, muscle fatigue during workouts can be a side effect of Lipitor, a medication used to treat high cholesterol levels. If you experience muscle fatigue or other muscle-related symptoms while taking Lipitor, it is essential to speak with a healthcare provider to determine the cause and appropriate course of action.

Sources:

1. DrugPatentWatch.com. (n.d.). Lipitor (Atorvastatin) Drug Patent Expiration & Generic Launch Dates. <https://www.drugpatentwatch.com/drugs/lipitor-atorvastatin>
2. Mayo Clinic. (2021, September 10). Statins: Are these cholesterol-lowering drugs right for you? <https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statins/art-20045786>
3. U.S. Food and Drug Administration. (2014, February 28). FDA adds information to labels of cholesterol-lowering statin drugs about potential risk of increased blood sugar and diabetes levels. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-adds-information-labels-cholesterol-lowering-statin-drugs-about-potential-risk-increased-blood-sugar>